Medtronic's Stealth AXiS Surgical Robot Secures CE Mark, Expanding AI-Powered Precision Surgery to Europe

May 01, 2026 08:01 CST Updated 08:01

Medtronic

Medical Device Manufacturer

Heavyweight Good News Hits the Medical Technology Circle Again!

Beijing time, April 28, 2026 – Medtronic (NYSE: MDT), a global medical device giant, officially announced that its Stealth AXiS surgical robot platform has successfully obtained EU CE certification. This means that this "surgical marvel," which integrates AI and robotic technology, has been officially approved to enter the European market, offering European patients undergoing spinal and cranial surgeries more precise and safer treatment options.

To know, CE certification is not an ordinary "pass", especially under the strict regulatory environment of the EU MDR (Medical Device Regulation) which will be fully implemented in 2026. Being able to successfully obtain the certification is enough to prove the hardcore strength of this robot - MDR has significantly increased the requirements for clinical evidence and strengthened post-market surveillance. Those who can pass the review are the best in the industry.

More notably, this is already the third major breakthrough for Stealth AXiS this year! At the beginning of 2026, it successively received two approvals from the U.S. FDA—first for spinal surgery indications, and then for cranial and ENT surgeries. Now, with the addition of CE certification, it has effectively secured access to both major markets in Europe and America, maintaining an unstoppable momentum.

Just last week, a spine center in Virginia, USA, became the world's first institution to use Stealth AXiS for surgery, marking the official transition of this robotic system from "approval" to "clinical implementation" and beginning to truly serve patients.

Some may ask, what's so impressive about this surgical robot? Why has it been successively recognized by the world’s top regulatory agencies?

The answer is simple: it takes "precision" and "flexibility" to the extreme, and perfectly aligns with the operating habits of clinicians.

PART.01

Core Design Advantages

When designing the Stealth AXiS, Medtronic did not blindly pursue "piling up high-tech gadgets." Instead, based on its mature Mazor spinal robot and StealthStation navigation technology, it created a modular robotic platform—hospitals can flexibly deploy the required functions according to their needs, and can upgrade as clinical requirements evolve, without having to invest excessive costs all at once, maximizing practicality.

And its core competitiveness lies in the AI-empowered architecture:

Spinal Surgery: Equipped with LiveAlign segment tracking technology, doctors can see the movement of the patient's bones and body alignment in real time during surgery, as if adding "real-time navigation" to the procedure. There’s no longer a need to worry about operational deviations caused by slight movements of the patient, greatly improving surgical accuracy.

Brain Surgery: AI-driven automatic fiber tract imaging technology helps doctors create tailored brain maps for patients, clearly "visualizing" neural pathways related to key functions such as language and movement—keep in mind that brain surgery has an extremely low error tolerance, and more precision means less risk of nerve damage, which is crucial for the patient's postoperative recovery.

In addition, Medtronic has also partnered with GE Healthcare to integrate this robotic platform with intraoperative ultrasound technology, further enhancing visualization during surgery, allowing doctors to see more clearly and operate more steadily.

PART.02

Significance for the European Market

For European patients, the arrival of Stealth AXiS means they will be able to enjoy more unified and efficient precision surgical services. Given the diversity of European healthcare systems and the varying technical levels across institutions, this robotic system integrates preoperative planning, intraoperative navigation, and robotic guidance into a streamlined process, helping doctors implement "precision" in every surgery and making personalized treatment no longer a "luxury."

Oli Prosperi, Vice President of International Business for Medtronic's Cranial and Spinal Technologies, stated: "The CE certification of Stealth AXiS marks a significant milestone in expanding access to advanced surgical technologies in Europe. Securing this certification under the stringent EU MDR regulations also demonstrates our commitment to delivering meaningful innovation across diverse healthcare environments."

Michael Carter, Senior Vice President and President of Medtronic's Cranial and Spinal Technologies, added: "Introducing Stealth AXiS to Europe is an important step in our effort to build a connected platform — by integrating planning, navigation, and robotic guidance, we help surgeons turn clinical insights into surgical actions, making surgeries more predictable, more personalized, and laying a solid foundation for future healthcare innovation."

PART.03

Industry Impact and Future Outlook

As the "leader" in the global medical device field, Medtronic has long had a profound presence in the surgical robotics sector, from the Mazor spinal robot to the Stealth Autoguide neurosurgical robot, and now the Stealth AXiS. It consistently focuses on the core principles of "precision, safety, and efficiency" to drive innovation in surgical models.

The implementation of this CE certification is not only an important step in Medtronic's global strategic layout but also marks the entry of global precision surgery into a new era of "AI + robotics." In the future, with the widespread application of this robotic system in Europe, patients from more countries and regions may benefit, making "minimally invasive, precise, and safe" surgeries a preferred choice for more people.

? Follow us to unlock the latest global medical technology trends in real time and witness more life-changing medical breakthroughs!